These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 24305709)

  • 1. Tight junction protein claudin-1 is differentially expressed in craniopharyngioma subtypes and indicates invasive tumor growth.
    Stache C; Hölsken A; Fahlbusch R; Flitsch J; Schlaffer SM; Buchfelder M; Buslei R
    Neuro Oncol; 2014 Jan; 16(2):256-64. PubMed ID: 24305709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.
    Wang Y; Deng J; Guo G; Tong A; Peng X; Chen H; Xu J; Liu Y; You C; Zhou L
    J Neurooncol; 2017 Jan; 131(1):21-29. PubMed ID: 27640198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles.
    Hölsken A; Sill M; Merkle J; Schweizer L; Buchfelder M; Flitsch J; Fahlbusch R; Metzler M; Kool M; Pfister SM; von Deimling A; Capper D; Jones DT; Buslei R
    Acta Neuropathol Commun; 2016 Feb; 4():20. PubMed ID: 26927026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of aberrant beta-catenin and impaired p63 in craniopharyngiomas.
    Cao J; Lin JP; Yang LX; Chen K; Huang ZS
    Br J Neurosurg; 2010 Jun; 24(3):249-56. PubMed ID: 20128632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adamantinomatous craniopharyngiomas express tumor stem cell markers in cells with activated Wnt signaling: further evidence for the existence of a tumor stem cell niche?
    Hölsken A; Stache C; Schlaffer SM; Flitsch J; Fahlbusch R; Buchfelder M; Buslei R
    Pituitary; 2014 Dec; 17(6):546-56. PubMed ID: 24356780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas.
    Burghaus S; Hölsken A; Buchfelder M; Fahlbusch R; Riederer BM; Hans V; Blümcke I; Buslei R
    Virchows Arch; 2010 Mar; 456(3):287-300. PubMed ID: 20069432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of CLAUDIN-1 on follicular thyroid carcinoma aggressiveness.
    Zwanziger D; Badziong J; Ting S; Moeller LC; Schmid KW; Siebolts U; Wickenhauser C; Dralle H; Fuehrer D
    Endocr Relat Cancer; 2015 Oct; 22(5):819-30. PubMed ID: 26219679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling.
    Hölsken A; Buchfelder M; Fahlbusch R; Blümcke I; Buslei R
    Acta Neuropathol; 2010 May; 119(5):631-9. PubMed ID: 20131060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can recurrences be predicted in craniopharyngiomas? β-catenin coexisting with stem cells markers and p-ATM in a clinicopathologic study of 45cases.
    Guadagno E; de Divitiis O; Solari D; Borrelli G; Bracale UM; Di Somma A; Cappabianca P; Del Basso De Caro M
    J Exp Clin Cancer Res; 2017 Jul; 36(1):95. PubMed ID: 28709442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma.
    Chao YC; Pan SH; Yang SC; Yu SL; Che TF; Lin CW; Tsai MS; Chang GC; Wu CH; Wu YY; Lee YC; Hong TM; Yang PC
    Am J Respir Crit Care Med; 2009 Jan; 179(2):123-33. PubMed ID: 18787218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL12/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K/AKT signal pathway.
    Yin X; Liu Z; Zhu P; Wang Y; Ren Q; Chen H; Xu J
    J Cell Biochem; 2019 Jun; 120(6):9724-9736. PubMed ID: 30582214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of cytokeratins 8 and 20 distinguishes craniopharyngioma from rathke cleft cyst.
    Xin W; Rubin MA; McKeever PE
    Arch Pathol Lab Med; 2002 Oct; 126(10):1174-8. PubMed ID: 12296753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug priming enhances radiosensitivity of adamantinomatous craniopharyngioma via downregulation of survivin.
    Stache C; Bils C; Fahlbusch R; Flitsch J; Buchfelder M; Stefanits H; Czech T; Gaipl U; Frey B; Buslei R; Hölsken A
    Neurosurg Focus; 2016 Dec; 41(6):E14. PubMed ID: 27903123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EpCAM (CD326) is differentially expressed in craniopharyngioma subtypes and Rathke's cleft cysts.
    Thimsen V; Hölsken A; Buchfelder M; Flitsch J; Fahlbusch R; Stefanits H; Losa M; Jones DT; Buslei R
    Sci Rep; 2016 Jul; 6():29731. PubMed ID: 27431859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma.
    Zhang Z; Wang A; Sun B; Zhan Z; Chen K; Wang C
    J Cardiothorac Surg; 2013 Apr; 8():95. PubMed ID: 23591077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of claudin-18 is associated with the proliferative and invasive potential of gastric cancer at the invasive front.
    Oshima T; Shan J; Okugawa T; Chen X; Hori K; Tomita T; Fukui H; Watari J; Miwa H
    PLoS One; 2013; 8(9):e74757. PubMed ID: 24073219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth patterns of craniopharyngiomas: clinical analysis of 226 patients.
    Pan J; Qi S; Liu Y; Lu Y; Peng J; Zhang X; Xu Y; Huang GL; Fan J
    J Neurosurg Pediatr; 2016 Apr; 17(4):418-33. PubMed ID: 26636252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma.
    Kato K; Nakatani Y; Kanno H; Inayama Y; Ijiri R; Nagahara N; Miyake T; Tanaka M; Ito Y; Aida N; Tachibana K; Sekido K; Tanaka Y
    J Pathol; 2004 Jul; 203(3):814-21. PubMed ID: 15221941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of β-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases.
    Malgulwar PB; Nambirajan A; Pathak P; Faruq M; Suri V; Sarkar C; Jagdevan A; Sharma BS; Sharma MC
    J Neurooncol; 2017 Jul; 133(3):487-495. PubMed ID: 28500561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.